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Abstract 
Background: Microbial lipids are produced by many oleaginous organisms including the well-characterized yeast 
Yarrowia lipolytica, which can be engineered for increased lipid yield by up-regulation of the lipid biosynthetic path-
way and down-regulation or deletion of competing pathways.
Results: We describe a strain engineering strategy centered on diacylglycerol acyltransferase (DGA) gene overexpres-
sion that applied combinatorial screening of overexpression and deletion genetic targets to construct a high lipid 
producing yeast biocatalyst. The resulting strain, NS432, combines overexpression of a heterologous DGA1 enzyme 
from Rhodosporidium toruloides, a heterlogous DGA2 enzyme from Claviceps purpurea, and deletion of the native TGL3 
lipase regulator. These three genetic modifications, selected for their effect on lipid production, enabled a 77 % lipid 
content and 0.21 g lipid per g glucose yield in batch fermentation. In fed-batch glucose fermentation NS432 pro-
duced 85 g/L lipid at a productivity of 0.73 g/L/h.
Conclusions: The yields, productivities, and titers reported in this study may further support the applied goal of cost-
effective, large -scale microbial lipid production for use as biofuels and biochemicals.
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Background
Microbial lipid production has received applied interest 
both for the synthesis of specialty chemicals and for the 
production of fuels and bulk chemicals from low-cost 
carbon feedstocks [1]. Considering the high demand for 
lipid molecules, augmentation of current plant- and ani-
mal-based production by microbial conversion of starch 
and sugar crops, agricultural residues, and lignocellulosic 
material has been the subject of many recent studies. 
Among natively oleaginous organisms, which are capable 
of producing lipids at a level greater than 20  % of their 
dry cell weight, the well-characterized yeast Yarrowia 
lipolytica [2] has received particular interest. Wild-type 
Y. lipolytica can accumulate lipids up to 36 % of dry cell 
weight from glucose [3] and 50–60 % of dry cell weight 
when fed exogenous fatty acid substrates for biomodifi-
cation to higher value fats and oils [4, 5], and research-
ers have metabolically engineered strains to produce high 
value lipids [6–8]. In addition to production and bio-
modification of lipids, Y. lipolytica strains are capable of 
secreting low-molecular weight secondary metabolites 
such as citric acid and polyols, and extracellular enzymes 
under specific fermentation conditions [9, 10]. Extensive 
genetic systems have been developed to manipulate this 
yeast [9, 11, 12].
Lipids serve as energy storage molecules and building 
blocks for cellular membranes and are composed of fatty 
acids, isoprenoids, and other water-insoluble hydrocar-
bon molecules. In many oleaginous yeasts, fatty acids 
are the dominant lipid compound, constituting 90–95 % 
of total lipid material [13, 14]. To avoid the potentially 
toxic and membrane-disturbing effects of free fatty acids, 
they are incorporated into nonpolar lipids such as tria-
cylglycerols (TAG) and sterol esters. TAGs are stored in 
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subcellular compartments termed lipid droplets or lipid 
bodies [15–18].
Several applied studies have focused on increasing 
TAG production through genetic engineering of TAG 
synthesis and degradation pathways [19–21], including 
recent publications that have pushed previous limits of Y. 
lipolytica lipid productivity and titer [22–24]. A series of 
proteins were postulated as regulators of the conversion 
of carbohydrate sources into TAGs: malic enzyme (ME), 
ATP citrate lyase (ACL), Acetyl-CoA carboxylase (ACC), 
Bifunctional glycerol-3-phosphate/glycerone-phosphate 
O-acyltransferase (SCT), 1-acylglycerol-3-phosphate 
O-acyltransferase (SLC1), Stearoyl-CoA desaturase 
(SCD), and phospholipid: diacylglycerol Acyltransferase 
(LRO) (Fig. 1).
In particular, the enzymes DGA1 (diacylglycerol acyl-
transferase type 2) and DGA2 (diacylglycerol acyltrans-
ferase type 1) have been recognized as key components 
of the lipid pathway, performing the final step of TAG 
synthesis, incorporation of the third acyl-CoA onto the 
diacylglycerol backbone and transport into the lipid 
droplet [23]. Up-regulation of the native Y. lipolytica 
DGA1 and DGA2 enzymes have significantly increased 
lipid yield and productivity [19, 21, 26], and it has been 
hypothesized that efficient diacylglycerol acyltransferase 
activity creates a critical driving force for high levels of 
lipid accumulation in oleaginous organisms due to its 
dual role in TAG biosynthesis and transport into the lipid 
droplet [19, 27, 28]. Additionally, it has been shown that 
the deletion of DGA2 impairs TAG synthesis and lipid 
production in Y. lipolytica [25]. It has also been demon-
strated that DGA1 or DGA2 overexpression is beneficial 
for lipid accumulation in R. toruloides [29] as well as in 
plant seeds [30].
In this study, we describe a systematic lipid biosyn-
thesis engineering approach centered on diacylglycerol 
acyltransferase gene overexpression. First, we evaluated 
combinations of endogenous gene targets and then we 
optimized key enzymes by screening heterologous genes 
for engineering of an improved lipid-accumulating bio-
catalyst. The resulting strain of this process reached a 
77 % lipid content and a 0.21 g lipid per g glucose yield 
in batch glucose fermentation, while in fed-batch glu-
cose fermentation it produced 85 g/L lipid at a 0.73 g/L/h 
productivity.
Results/discussion
Overexpression of endogenous DGA1 in Yarrowia lipolytica
In an effort to develop a biocatalyst for industrial lipid 
production, we evaluated several Y. lipolytica wild-type 
strains for desirable biocatalyst qualities, such as minimal 
citric acid secretion, non-hyphal morphology, and ease 
of genetic manipulation. We isolated one such strain, 
designated NS18 (obtained from NRRL # YB-392), for 
future strain engineering. Previous studies have identi-
fied several endogenous genes which improve lipid pro-
duction when overexpressed or deleted in Y. lipolytica 
[19, 21, 25, 31]. One of these genes, DGA1, encoding for 
diacylglycerol acyltransferase type 2, is involved in the 
final step of TAG synthesis [2, 19, 21, 25, 32–36] and has 
been a key genetic up-regulation target to increase pro-
duction of TAG from glucose in independent Y. lipolytica 
studies [19, 21].
In order to evaluate the effect of DGA1 overexpres-
sion in NS18, the Y. lipolytica DGA1 gene (NG15) was 
introduced into the NS18 genome under the control of 
the strong constitutive GPD1 promoter to produce strain 
Fig. 1 Major steps of lipid biosynthesis in Y. lipolytica. Overexpression 
genetic targets screened in this study for their effect on lipid produc-
tion are shown in green boxes. Deletion genetic targets are shown in 
red boxes
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NS297. Although use of promoters with varied expres-
sion levels may allow for a higher degree of metabolic 
balancing and control, we felt strongly constitutive pro-
moters were suitable for identifying targets for lipid bio-
synthesis overexpression. To produce engineered strains, 
50–200 transformants were screened in 96- or 48-well 
plates and evaluated by fluorescence-based assay for lipid 
content. The top isolates were then tested in 50-mL shake 
flasks and the highest performing strains were grown in 
1 L bioreactors using a high cell density fed-batch glucose 
fermentation process followed by gas chromotograph 
(GC) lipid content analysis. Lipid content measured by 
GC is reported as fatty acid methyl ester equivalents, as 
described in the methods section. NS297 transformants 
exhibited a twofold increase in lipid content compared to 
wild-type Y. lipolytica NS18 as evaluated by fluorescence 
assay (Figs. 2, 4a, b) and GC analysis (Fig. 4b).
Screening heterologous DGA1 genes for increased lipid 
production
Given the effectiveness of endogenous DGA1 over-
expression in Y. lipolytica, we next sought to express 
DGA1 from oleaginous organisms that natively attain 
lipid at 50 % or more of their dry weight and have publi-
cally accessible genome sequences [3, 37–40]. We chose 
DGA1 genes from five such organisms: Rhodosporid-
ium toruloides, Lipomyces starkeyi, Aurantiochytrium 
limacinum, Aspergillus terreus, and Claviceps purpu-
rea. Three versions of the R. toruloides DGA1 gene were 
expressed in Y. lipolytica: NG49—the native R. toruloides 
DGA1 gene amplified from R. toruloides genomic DNA; 
NG66—a synthetic gene containing R. toruloides DGA1 
cDNA without introns; and NG67—a synthetic gene 
containing R. toruloides DGA1 cDNA without introns 
and codon optimized for expression in Y. lipolytica. Two 
versions of L. starkeyi DGA1 were expressed in Y. lipo-
lytica: NG68—a synthetic gene containing L. starkeyi 
DGA1 cDNA without introns; and NG69—a synthetic 
gene containing L. starkeyi DGA1 cDNA without introns 
and codon optimized for expression in Y. lipolytica. A. 
limacinum (NG70), A. terreus (NG71), and C. purpurea 
(NG72) DGA1 genes were synthesized without introns 
and codon optimized for expression in Y. lipolytica. A 
total of nine different DGA1 genes were expressed in Y. 
lipolytica under the same strong Y. lipolytica GPD1 pro-
moter (Table 2). Expression of all nine DGA1 genes had 
a positive effect on lipid content in Y. lipolytica (Fig. 2). 
Due to the random, non-targeted nature of integration, 
which can result in a range of DGA1 expression, the 
diversity we saw in transformants’ lipid accumulation was 
not unexpected. Additionally, there is the potential for 
multiple DGA1 expression vector copies to simultane-
ously integrate during genetic transformation. To inves-
tigate the likelihood of our results being influenced by 
DNA copy number, we performed an experiment where 
two independent, non-linked selectable markers were co-
transformed and the frequency of selectable marker co-
expression was measured (Additional file  1: Figure S1). 
This test indicated that for the DNA loadings used in this 
study (approximately 1  μg vector DNA/transformation) 
the frequency of two copies simultaneously integrating is 
6 % of total transformants.
Transformants that demonstrated the highest fluo-
rescence output per optical density were generated by 
overexpression of R. toruloides DGA1 (NG66, NG67) 
and L. starkeyi DGA1 (NG68). These achieved lipid lev-
els approximately three-fold higher than NS18 and were 
also higher than transformants overexpressing the native 
Y. lipolytica DGA1 gene. The most effective DGA1 genes 
came from donors that were repeatedly reported to attain 
Fig. 2 Overexpression of DGA1 genes in Y. lipolytica strain NS18. Nine DGA1 genes (Table 2) under the control of the Y. lipolytica GPD1 promoter 
were randomly integrated into the NS18 genome and 8 transformants for each gene were analyzed by fluorescence-based lipid assay after 72 h of 
growth in nitrogen-limited media. The average with standard deviation from triplicate experiments is shown for the parent strain. Fluorescence was 
measured at excitation 486 nm and emission 510 nm and normalized by cell optical density (OD) at 600 nm
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the highest lipid contents among other oleaginous yeast 
strains [3, 41]. These results suggest that DGA1-specific 
activity and/or expression level could be a major factor 
driving lipid production levels in oleaginous yeasts. The 
effect of native R. toruloides DGA1 (NG49) overexpres-
sion on lipid production in Y. lipolytica was not as high as 
the effect of the synthetic versions of R. toruloides DGA1 
genes that did not contain introns. This result may indi-
cate that the heterologous R. toruloides DGA1 gene was 
not spliced efficiently in Y. lipolytica. Codon optimiza-
tion of R. toruloides and L. starkeyi DGA1 genes did not 
have a positive effect on lipid production over the native 
cDNA sequences.
The top lipid-producing isolate expressing the R. 
toruloides DGA1 gene was designated NS281. Strains 
expressing DGA1 from A. limacinum, A. terreus, and C. 
purpurea did not show substantial improvements in lipid 
content compared to strains overexpressing the native Y. 
lipolytica DGA1 gene (Fig. 2).
Screening additional genetic targets for increased lipid 
production in a DGA1 overexpression background
A secondary screen was designed to test the combina-
tion of DGA1 overexpression with other targets in the 
lipid accumulation pathway (Fig.  1). Secondary dele-
tion or overexpression targets, under the control of the 
Y. lipolytica EXP1 promoter, were integrated into strain 
NS125, which overexpresses the Y. lipolytica DGA1 gene 
under the control of the Y. lipolytica TEF1 promoter. Tar-
geted gene deletions were enabled by treatment of cells 
with hydroxyurea to arrest cell cycle division in the S 
phase during preparation of competent cells [42]. Table 1 
summarizes the relative effect of secondary deletion and 
overexpression targets on lipid content compared to 
the parental strain NS125. Four overexpression targets, 
GPD1, SLC1, DGA2, and LRO1, had a positive effect on 
lipid content when combined with DGA1. Interestingly, 
all four of these enzymes are involved in the last steps 
glycerol backbone synthesis and fatty acid attachment for 
triacylglycerol synthesis. Overexpression of the Y. lipol-
ytica DGA2 gene increased lipid content by nearly 65 % 
compared to the parental strain NS125, which was the 
highest increase among the targets tested. Due to a lim-
ited number of dominant genetic markers, DGA2 alone 
was selected for further investigation. DGA2 is located 
in the endoplasmic reticulum and is hypothesized to be 
responsible for TAG formation in newly formed lipid 
bodies, while DGA1 is located on the lipid body mem-
brane and its hypothesized function is to accumulate 
TAG within the same lipid body and increase its volume 
[43]. Considering that overexpression of homologous 
DGA2 alone in Y. lipolytica did not have as pronounced 
of an effect on lipid content (data not shown), the above 
data suggest that native DGA2 function is not limiting for 
Table 1 Relative lipid contents of strains with overexpressed or deleted genetic targets in addition to DGA1 overexpres-
sion
Lipid content was measured by fluorescence-based lipid assay after 96 h of fermentation in 48-well plates and normalized by the value corresponding to the parental 




WT Wild-type Yarrowia lipolytica strain 0.55 ± 0.02
DGA1 (NS125) Diacylglycerol acyltransferase; catalyzes the terminal step of triacylglycerol (TAG) formation, acylates  
diacylglycerol using acyl-CoA as an acyl donor
1.00 ± 0.09
DGA1 Δgut2 Mitochondrial glycerol-3-phosphate dehydrogenase 0.95 ± 0.12
DGA1 GPD1 NAD-dependent glycerol-3-phosphate dehydrogenase 1.12 ± 0.03
DGA1 ME Mitochondrial malic enzyme; catalyzes the oxidative decarboxylation of malate to pyruvate 0.92 ± 0.15
DGA1 ACL1/2 ATP citrate lyase 1 & 2 0.99 ± 0.09
DGA1 ACC1 Acetyl-CoA carboxylase subunit 1 1.05 ± 0.19
DGA1 SCT1 Bifunctional glycerol-3-phosphate/glycerone-phosphate O-acyltransferase 1.03 ± 0.01
DGA1 SLC1 1-acylglycerol-3-phosphate O-acyltransferase 1.25 ± 0.07
DGA1 SCD1 Stearoyl-CoA desaturase. Endoplasmic reticulum (ER) protein that catalyzes the Δ9-cis desaturation of 
saturated fatty acids
0.85 ± 0.18
DGA1 DGA2 DGAT1 acyl-CoA:diacylglycerol acyltransferase family 1.62 ± 0.03
DGA1 LRO1 Acyltransferase that catalyzes diacylglycerol esterification; one of several acyltransferases that contribute 
to triglyceride synthesis
1.33 ± 0.07
DGA1 Δtgl3 Bifunctional triacylglycerol lipase. Major lipid particle-localized triacylglycerol (TAG) lipase 0.79 ± 0.24
DGA1 Δtgl4 Multifunctional lipase/hydrolase/phospholipase; triacylglycerol lipase, steryl ester hydrolase, and 
Ca2 + -independent phospholipase A2
1.03 ± 0.08
DGA1 Δmfe1 Multifunctional enzyme, member of the peroxisomal hydroxyacyl coenzyme A dehydrogenase family 0.89 ± 0.03
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TAG formation in NS18 wild-type Y. lipolytica but may 
become a limiting factor once DGA1 activity is abundant.
Screening heterologous DGA2s for increased lipid 
production in a DGA1 overexpression background
In order to identify a DGA2 with higher activity and/
or expression than that of Y. lipolytica, DGA2 genes 
(Table 2) from six donors (Y. lipolytica, R. toruloides, L. 
starkeyi, A. terreus, C. purpurea, Chaetomium globosum) 
were expressed in Y. lipolytica strains NS125 and NS281 
(overexpressing Y. lipolytica and R. toruloides DGA1 
genes, respectively).
The effect of different DGA2 genes on lipid content 
measured by fluorescence-based lipid assay is shown 
in Fig.  3. The effect of DGA2 overexpression was more 
noticeable in the NS125 strain background (Fig. 3a), pos-
sibly due to lower baseline lipid content in this strain than 
in NS281 (Fig. 3b). In both NS125 and NS281 strains, C. 
purpurea DGA2 (NG112) overexpression yielded the 
highest increase in lipid content.
Deletion of TGL3 increased lipid accumulation at the end 
of fermentation
TGL3 is one of two intracellular lipases responsible 
for the first step of lipid body localized TAG degrada-
tion in Y. lipolytica [16, 31]. It has been suggested that 
TGL3 positively regulates TGL4, the primary lipase, but 
may not have lipase activity on its own, as it lacks a key 
amino acid motif that is specific for lipase activity [31]. 
TGL3 or TGL4 deletions in the NS125 background did 
not increase lipid content after 96  h of fermentation in 
smaller scale experiments (Table  1). However, as these 
genes are directly or indirectly involved in the break-
down of TAG, we hypothesized that their activity would 
be critical at the end of the bioprocess, when carbon is 
exhausted and cells attempt to recover stored carbon 
from lipids. We compared lipid levels at late time-points 
in the strain overexpressing R. toruloides NG66 DGA1 
alone (NS281) and the strain combining NG66 over-
expression and TGL3 deletion (NS377). Strain NS377 
accumulated higher lipid content than NS281 after 140 h 
of fermentation both in 50-mL shake flasks (data not 
shown) and in 1 L bioreactors (Fig. 4c). These results indi-
cate that down-regulation of the TAG degradation path-
way is beneficial for lipid content late in the bioprocess. 
Strains with a TGL4 deletion also had a positive effect on 
lipid content late in the fermentation but reduced overall 
lipid titer due to a negative effect on overall cell growth 
(data not shown).
Combination of the best lipid accumulation genetic 
modifications
In order to combine a TGL3 deletion with the R. toru-
loides DGA1 and C. purpurea DGA2 gene overexpres-
sions, C. purpurea DGA2 was overexpressed in strain 
NS377 resulting in strain NS432 (genotype: RtDGA1 nat 
Table 2 Description of DGA1 and DGA2 genes overexpressed in Yarrowia lipolytica
Gene sequences are given in Additional file 1
Gene Source Description
NG15 Yarrowia lipolytica native Y. lipolytica DGA1 gene amplified form Y. lipolytica genomic DNA
NG49 Rhodosporidium toruloides native R. toruloides DGA1 gene amplified form R. toruloides genomic DNA
NG66 Rhodosporidium toruloides synthetic gene containing R. toruloides DGA1 cDNA without introns
NG67 Rhodosporidium toruloides synthetic gene containing R. toruloides DGA1 cDNA without introns and codon optimized 
for expression in Y. lipolytica
NG68 Lipomyces starkeyi synthetic gene containing L. starkeyi DGA1 cDNA without introns
NG69 Lipomyces starkeyi synthetic gene containing L. starkeyi DGA1 cDNA without introns and codon optimized  
for expression in Y. lipolytica
NG70 Aurantiochytrium limacinum synthetic gene containing A. limacinum DGA1 cDNA without introns and codon optimized 
for expression in Y. lipolytica
NG71 Aspergillus terreus synthetic gene containing A. terreus DGA1 cDNA without introns and codon optimized  
for expression in Y. lipolytica
NG72 Claviceps purpurea synthetic gene containing C. purpurea DGA1 cDNA without introns and codon optimized 
for expression in Y. lipolytica
NG16 Yarrowia lipolytica native Y. lipolytica DGA2 gene amplified form Y. lipolytica genomic DNA
NG109 Rhodosporidium toruloides synthetic gene containing R. toruloides DGA2
NG110 Lipomyces starkeyi synthetic gene containing L. starkeyi DGA2
NG111 Aspergillus terreus synthetic gene containing A. terreus DGA2
NG112 Claviceps purpurea synthetic gene containing C. purpurea DGA2
NG113 Chaetomium globosum synthetic gene containing C. globosum DGA2
Page 6 of 12Friedlander et al. Biotechnol Biofuels  (2016) 9:77 
CpDGA2 zeo tgl3Δ::hyg). NS432 reached higher lipid 
contents than any of the previously generated strains 
(Fig. 4). As expected from our results with NS377, when 
grown in 48-well plates or 50-mL flasks for 96 h, NS432 
did not demonstrate lipid-content increase over NS450, 
a strain carrying only the overexpression targets R. toru-
loides DGA1 and C. purpurea DGA2 (Fig.  4a, b). Con-
sistent with a late fermentation role for TGL3 in TAG 
degradation, NS432 achieved a significantly higher lipid 
content compared to NS450 when grown for 140  h in 
50-mL shake flasks (data not shown) or 1-L bioreactors 
(Fig. 4c).
To study in depth the productivity and the yield that 
could be reached with NS432, two sets of conditions 
were explored in 1-L bioreactors. Figure 5 shows batch 
(a) and fed-batch (b) glucose fermentations of NS432 
and wild-type NS18. The calculated lipid production 
parameters are shown in Table  3. Data in Fig.  5 and 
Table  3 demonstrate that there is a trade-off between 
biomass and lipid production for the two different 
processes. In the batch bioprocess (carbon to nitro-
gen ratio of approximately 180), NS432 reached a lipid 
content of 77 % and a yield 0.21 g lipid per g glucose. In 
the fed-batch fermentation with a carbon to nitrogen 
ratio of approximately 110, NS432 produced a higher 
lipid free cell biomass resulting in an 85  g/L lipid titer 
and 0.73 g/L/h productivity, although at a slightly lower 
lipid content (73 %) and yield (0.20 g/g) than in the batch 
process. 
The stoichiometric pathway yield for TAG lipid pro-
duction in Y. lipolytica based on known biochemistry for 
this organism has been calculated at 0.276  g per gram 
glucose [44]. However, this value does not include the 
expenditure of glucose to produce and maintain non-
storage lipid yeast biomass, an important consideration 
for applied microbial lipid production since the amount 
Fig. 3 Overexpression of DGA2 genes in Y. lipolytica. Six DGA2 genes (Table 2) under the control of the Y. lipolytica TEF1 promoter were overex-
pressed in NS125 (a) and NS281 (b) strains that overexpress DGA1 from Y. lipolytica and R. toruloides, respectively. Fifteen transformants for each 
gene were analyzed by fluorescence-based lipid assay after 72 h of growth in nitrogen-limited media. The average with standard deviation from 
triplicate experiments is shown for the parent strain. Fluorescence was measured at excitation 486 nm and emission 510 nm and normalized by cell 
optical density (OD) at 600 nm
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of non-lipid biomass (i.e., catalyst) and its cell specific 
lipid productivity determines the rate of lipid production. 
As shown in Table 4, this study adds to recent literature 
indicating that Y. lipolytica can be engineered for highly 
effective lipid production. The batch lipid yield, fed-batch 
titer, and productivity reported here are among the high-
est reported [22, 23, 44] and approaches the maximal 
values predicted by Y. lipolytica lipid biochemistry and 
co-production of non-storage lipid biomass.
Conclusions
In this study, we describe a strain engineering strategy 
that applied screening of endogenous and heterologous 
targets and target combinations for the construction of 
a high lipid-producing yeast biocatalyst. First, we con-
firmed that the overexpression of DGA1 increased lipid 
content in Y. lipolytica. A secondary screen identified 
genes that boosted lipid accumulation when overex-
pressed or deleted in combination with DGA1 overex-
pression. We then searched for heterologous DGA1 and 
DGA2 genes that would outperform the native enzymes 
in lipid accumulation and identified R. toruloides DGA1 
and C. purpurea DGA2. Finally, we found that dele-
tion of TGL3 reduces TAG degradation during the late 
phase of the bioprocess when nutrients are limited and 
lipase-mediated TAG mobilization is triggered. The 
yields, productivities, and titers reported in this study 
may further support the applied goal of developing Y. 
lipolytica for cost effective microbial lipid production. 
Additionally, several studies have demonstrated the 
ability to expand Y. lipolytica’s substrate range to low-
cost feedstocks such as sucrose [45], xylose [46], cello-
biose and lignocellulosic biomass [47], and starch [48]. 
Researchers have also investigated continuous culture 
[49, 50] as a lower cost processing method than batch 
or fed-batch fermentation. The combined actions of 
attaining high lipid titer with low-cost feedstock utili-
zation and advanced processing strategies should help 
enable use of this yeast for production of biofuels and 
biochemicals.
Methods
Strains, media, and cultivation methods
Wild-type Y. lipolytica strain YB-392 was obtained from 
the ARS (NRRL) culture collection. For routine main-
tenance and genetic transformation, strains were cul-
tured in YPD (10 g/L yeast extract, 20 g/L bacto peptone, 
20 g/L glucose) with the addition of 20 g/L agar for solid 
media and 300 μg/mL hygromycin B (Corning), 500 μg/
mL nourseothricin (Werner Bioreagents) or 1  mg/mL 
zeocin (Invitrogen) for antibiotic selection. All Yarrowia 
strains were cultured at 30 °C.
Media and growth conditions used in this study for 
Escherichia coli were previously described by Sambrook 
Fig. 4 Comparison of lipid accumulation in Y. lipolytica strains with different target combinations by different methods. a Strains analyzed by fluo-
rescence assay after 96 h of fermentation in a 48-well plate. Two or three transformants were analyzed for each construct and average with standard 
deviation is shown. b Strains analyzed by fluorescence assay and GC after 96 h of fermentation in 50-mL flasks. The measurement was done in 
triplicates and average with standard deviation is shown. c Strains analyzed by GC after 140 h of fermentation in 1 L bioreactors. With exception for 
NS450 the measurement was done in duplicates and average with standard deviation is shown
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Fig. 5 Evaluation of high lipid Y. lipolytica strain NS432 performance in 1 L bioreactor as compared to the parental strain NS18 in batch (a) and fed-
batch (b) fermentation. Dry cell weight, glucose consumption, citrate and lipids (reported as fatty acid methyl esters) were monitored throughout 
the fermentation. All experiments except for NS18—batch were performed twice and the average with standard deviation from duplicate experi-
ments are shown
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and Russell [51], those for Saccharomyces cerevisiae by 
Shanks et al. [52], and those for Y. lipolytica by Barth and 
Gaillardin [9].
Medium used for fluorescence assay in 96-well or 
48-well plates, and shake flasks was: urea (0.5 g/L), yeast 
extract (1.5 g/L), casamino acids (0.85 g/L), YNB without 
Table 3 Lipid production parameters calculated for the final time point (120 h) of the batch and fed-batch fermentation 
experiments with strains NS18 and NS432
All experiments except for NS18—batch were performed twice and the average with standard deviation from duplicate experiments is shown
a  Cell specific productivity calculated over 20–70-h post-inoculation
b  Yields calculated for batch cultivation account for a measured 10 % volume loss due to sampling and aeration over the course of fermentation
NS18 NS432
Batch Fed-batch Batch Fed-batch
Hours post-inoculation 116 116 114 115
Lipid content (% w lipid/w DCW) 24 % 25 % ± 4 % 77 % ± 2 % 73 % ± 2 %
Titer (g lipid/L) 3.6 12.8 ± 1.0 30.8 ± 1.8 84.5 ± 1.7
Productivity (g lipid L−1 h−1) 0.03 0.11 ± 0.01 0.27 ± 0.02 0.73 ± 0.01
Cell specific productivitya (g lipid g lipid free DCW−1 h−1) 0.002 0.003 ± 0.001 0.048 ± 0.006 0.044 ± 0.001
Yield (g lipid/g glucose consumed)b 0.06 0.07 ± 0.01 0.21 ± 0.004 0.20 ± 0.004
Table 4 Recently reported literature values for  lipid titer, yield, and  productivity with  engineered Yarrowia lipolytica 
strains





















po1g MTYL037 control strain 
(ura + lacZ)
Batch 80 2.5 0.03 0.02 0.002 [19]
po1g MTYL065 DGA1 ACC1 Batch 80 17.6 0.20 0.14 0.017 [19]




235 55 0.23 0.71 0.038 [22]
po1f po1f leu + ura + control strain Batch 80 3 0.04 0.02 0.001 [21]
po1f pex10 mfe1 




Batch 80 16.1 0.20 0.11 0.017 [21]
po1f pex10 mfe1 




Batch 160 25.3 0.16 0.21 – [21]
po1f L36 DGA1 





160 25 0.21 0.13 0.018 [24]




Batch 160 39.1 0.24 0.56 0.035 [23]
po1d JMY2593 control strain 
(SUC2)
Batch 60 2.6 0.04 0.04 0.004 [26]




Batch 60 6.5 0.11 0.09 0.010 [26]
NS18 NS18 wild-type Batch 60 3.6 0.06 0.04 0.002 this study
NS18 NS432 DGA1 DGA2 
Δtgl3
Batch 140 30.8 0.21 0.27 0.048 this study




430 84.5 0.20 0.73 0.044 this study
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amino acids and ammonium sulfate (1.7  g/L), glucose 
(100 g/L), potassium hydrogen phthalate buffer adjusted 
to pH 5.5 (5.1 g/L).
Initial concentrations of medium for 1  L batch and 
fed-batch bioreactors was: glucose T0 (150  g/L), sen-
sient amberex 1003 yeast extract (3  g/L), sensient 
amberferm 4500 corn peptone (0.1  g/L), KH2PO4 
(4  g/L), MgSO4·7H2O (2  g/L), CaCl2·6H2O (0.8  g/L), 
NaCl (0.4  g/L), thiamine (12  mg/L), biotin (1  mg/L), 
trace elements [Na2MoO4·2H2O (160  mg/L), 
CuSO4·5H2O (0.2  mg/L), H3BO3 (40  mg/L), 
MnSO4·H2O (180  mg/L), FeCl2·6H2O (75  mg/L), 
ZnSO4·7H2O (20  mg/L)], and Antifoam 204 (Sigma-
Aldrich) (1  mL/L). For the batch process, (NH4)2SO4 
was added at 0.5  g/L and in the fed-batch process at 
11  g/L for the initial reactor volume. Process param-
eters included an inoculum volume of 2  % from an 
overnight shake flask in YPD, pH control at 3.5 auto-
matically adjusted with 10 N sodium hydroxide, a tem-
perature of 30 °C, aeration at 0.3 vvm air, and agitation 
at 1000 rpm for both processes. For the fed-batch pro-
cess a glucose substrate feed was initiated after batch 
glucose consumption at a rate of 6.5 mL/h from 420 mL 
of a 75 % w/v concentrated glucose stock solution. The 
initial batch volume was 680 mL.
Genetic transformation
Y. lipolytica competent cells were prepared following the 
protocol of Chen et al. [53]. Cells were grown overnight 
spread on YPD plates, and grown cells were transferred 
from the plate with 1 mL water. 50 µl was aliquoted per 
transformation reaction, cells were centrifuged and the 
supernatant was discarded. 9  µl of each PCR product 
(without purification) and 92  µl of transformation mix 
(80  μL 60  % polyethylene glycol 4000, 5  µl 2  M dithi-
othreitol, 5 µl 2 M lithium acetate pH 6, 2 µl 10 mg/mL 
single-stranded salmon sperm DNA) was added to 
the cell pellet. The transformation reaction was mixed 
well by vortexing and heat shocked at 39  °C for 1  h. 
Cells were centrifuged, the supernatant discarded, cells 
were resuspended in 1  mL YPD, transferred to culture 
tubes and cultured overnight before plating on selec-




Standard molecular biology techniques were used in 
this study [51]. Restriction enzymes and DNA polymer-
ase were purchased from New England Biolabs (Ipswich, 
MA). Descriptions of plasmids used for gene overexpres-
sions and gene sequences are presented in Additional 
file 1.
For DGA1 overexpressions, the linear expression con-
struct included an expression cassette for different DGA1 
genes and for the nat1 gene used as a marker for selec-
tion of random chromosomal integrants with nourseo-
thricin. For DGA2 overexpressions, the linear expression 
construct included an expression cassette for DGA2 
genes and for the ble gene used as a marker for selection 
with zeocin. For each expression construct 15 transfor-
mants were analyzed by fluorescence lipid assay.
For overexpression of secondary target genes, the lin-
ear expression construct included an expression cassette 
for the gene of interest and for the hph gene used as a 
marker for selection with hygromycin.
Gene deletion in Yarrowia lipolytica
The Y. lipolytica TGL3, GUT2, TGL4 and MFE1 genes 
were deleted as follows: A two-fragment deletion cas-
sette was amplified by PCR from a plasmid containing 
the hygromycin resistance gene hph such that the hph 
gene was split into two fragments that overlapped and 
were flanked by ~50 bp of homology to the upstream and 
downstream regions of the coding sequence (Primers 
summarized on Additional file 1: Table S1). The resulting 
PCR fragments were co-transformed. Y. lipolytica grown 
overnight on solid YPD media was used to inoculate a 
25 mL YPD culture at OD600 = 0.5. After 3 h of growth, 
50  mM hydroxyurea was added [42]. Cells were har-
vested 2  h post hydroxyurea addition, and the standard 
transformation protocol was followed with washed cell 
pellets. Hygromycin resistant colonies were screened by 
PCR to confirm the absence of the gene and the presence 
of a specific product.
Lipid content measurement by fluorescence assay
Strains patched on YPD agar media were inoculated 
into fluorescent assay media volumes of 1.5  mL for 
24-well plates or 0.6 mL for 96-well plates or 50 mL for 
shake flasks. Plates were incubated at 30 °C for 96 h and 
900  rpm, at 70–90  % humidity in an Infors Multitron 
ATR shaker. The shake flasks were incubated at 30 °C for 
96 h and 200 rpm in a New Brunswick Scientific shaker. 
To measure fluorescence, 20  μL cells were mixed with 
20 μL of 100 % ethanol in microplates and incubated at 
4 °C for 30 min. A master mix containing 1 M potassium 
iodide, 1 mM bodipy 493/503, 0.5 µL dimethyl sulfoxide, 
1.5 µL of 60 % PEG 4000 and 27 µL water was then ali-
quoted into Costar black well/clear bottom plates (80 μL/
well) and 20 μL of the ethanol/cell mix was added. Fluo-
rescence was measured with a SpectraMax M2 spectro-
photometer (molecular devices) at excitation 484 nm and 
emission 510  nm. The optical density (OD) at 600  nm 
was measured in the same plate. Fluorescence correlated 
with lipid content measured by GC.
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Lipid extraction and GC analysis
Dried biomass, prepared by lyophilization of 1  mL 
fermentation samples washed with an equal volume 
of water, was subjected to acid-catalyzed transes-
terification with 0.5  N hydrochloric acid in methanol 
(20 ×  1 mL ampule, Sigma) at 85  °C for 90 min. After 
the transesterification was completed, the lipid-soluble 
components of the reaction mixture were separated 
from the water-soluble components using a two-phase 
liquid extraction by adding water and isooctane and 
subsequently analyzed with a capillary gas chroma-
tograph (GC) equipped with a robotic injector, flame 
ionization detector (Thermo Scientific Trace GC Ultra 
with AS 3000 autosampler) and HP-INNOWAX capil-
lary column (30 m × 0.25 mm × 0.15 micrometers, Agi-
lent). Quantification of the methyl-ester products was 
achieved with use of both an internal standard (13:0 or 
15:0 fatty acid) and various concentrations of an exter-
nal standard mixture (NHI-D, Supelco Analytical, Belle-
fonte, PA) of fatty acid methyl esters (FAMEs). Lipids 
were reported as FAME equivalents of 16:0, 16:1, 18:0, 
18:1, and 18:2 fatty acids, e.g., the amount of FAME 
resulting from lipid extraction and transesterification 
after accounting for transesterification efficiency via the 
internal standard.
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TAG: triacylglycerol; GC: gas chromatography; cDNA: complementary DNA; 
YPD: yeast extract, peptone, dextrose medium; YNB: yeast nitrogen base 
medium; FAME: fatty acid methyl ester; OD: optical density; WT: wild-type 
organism.
Authors’ contributions
JF, VT, AK, RN, MH, JS, and EB designed and performed molecular biology, 
metabolic engineering, and micro-scale lipid assay experiments. EG, AC, KM 
designed and performed bioreactor fermentation experiments. DC and JA 
performed analytical measurements. CS and GS conceived the study. JF, VT, JS, 
GS, and EB wrote and reviewed the manuscript. All authors read and approved 
the final manuscript.
Author details
1 Total New Energies, 5858 Horton Street, Emeryville, CA 94610, USA. 2 Novogy, 
Inc., 85 Bolton Street, Cambridge, MA 02140, USA. 3 Department of Chemical 
Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave., 
Cambridge, MA 02139, USA. 4 Present Address: Twist Bioscience, 455 Mission 
Bay Blvd South, San Francisco, CA 94158, USA. 5 Present Address: Evelo Thera-
peutics, 620 Memorial Dr., Cambridge, MA 02139, USA. 
Acknowledgements
We thank Drs. Cornel Verduyn and Hans van Dijken for helpful and stimulating 
discussions during the preparation of this manuscript. The study was sup-
ported by Novogy, Inc.
Additional file
Additional file 1: Contains a description of the multi-copy integration 
experiment, gene overexpression vectors, lipid biosynthesis pathway 
gene sequences used in this study, and primers used to construct gene 
knockout targets.
Competing interests
The authors are current employees, former employees, or otherwise affiliated 
with Novogy, Inc., which has a commercial interest in the strains described in 
this study. The authors declare no other non-financial competing interests.
Received: 23 December 2015   Accepted: 21 March 2016
References
 1. Donot F, Fontana A, Baccou JC, Strub C, Schorr-Galindo S. Single cell oils 
(SCOs) from oleaginous yeasts and moulds: production and genetics. 
Biomass Bioenergy. 2014;68:135–50.
 2. Beopoulos A, Cescut J, Haddouche R, Uribelarrea J-L, Molina-Jouve C, 
Nicaud J-M. Yarrowia lipolytica as a model for bio-oil production. Prog 
Lipid Res. 2009;48:375–87.
 3. Ratledge C, Wynn JP. The biochemistry and molecular biology of lipid accu-
mulation in oleaginous microorganisms. Adv Appl Microbiol. 2002;51:1–51.
 4. Bati N, Hammond EG, Glatz BA. Biomodification of fats and oils: trials with 
Candida lipolytica. J Am Oil Chem Soc. 1984;61:1743–6.
 5. Papanikolaou S, Chevalot I, Galiotou-Panayotou M, Komaitis M, Marc I, 
Aggelis G. Industrial derivative of tallow: a promising renewable substrate 
for microbial lipid, single-cell protein and lipase production by Yarrowia 
lipolytica. Electron J Biotechn. 2007;10:425–35.
 6. Ledesma-Amaro R, Nicaud J-M. Yarrowia lipolytica as a biotechnologi-
cal chassis to produce usual and unusual fatty acids. Prog Lipid Res. 
2016;61:40–50.
 7. Beopoulos A, Verbeke J, Bordes F, Guicherd M, Bressy M, Marty A, Nicaud 
J-M. Metabolic engineering for ricinoleic acid production in the oleagi-
nous yeast Yarrowia lipolytica. Appl Microbiol Biotechnol. 2014;98:251–62.
 8. Zhu Q, Jackson EN. Metabolic engineering of Yarrowia lipolytica for indus-
trial applications. Curr Opin Biotechnol. 2015;36:65–72.
 9. Barth G, Gaillardin C. Yarrowia lipolytica. Berlin: Springer; 1996:313–388.
 10. Gonçalves FAG, Colen G, Takahashi JA. Yarrowia lipolytica and its mul-
tiple applications in the biotechnological industry. Scientific World J. 
2014;2014:476207–14.
 11. Fischer CR, Klein-Marcuschamer D, Stephanopoulos G. Selection and 
optimization of microbial hosts for biofuels production. Metab Eng. 
2008;10:295–304.
 12. Lee SK, Chou H, Ham TS, Lee TS, Keasling JD. Metabolic engineering of 
microorganisms for biofuels production: from bugs to synthetic biology 
to fuels. Curr Opin Biotechnol. 2008;19:556–63.
 13. Papanikolaou S, Aggelis G. Part I: lipids of oleaginous yeasts. Biochemistry 
of single cell oil production. Eur J Lipid Sci Tech. 2011;113:1031–51.
 14. Papanikolaou S, Aggelis G. Lipids of oleaginous yeasts. Part II: technology 
and potential applications. Eur J Lipid Sci Tech. 2011;113:1052–73.
 15. Zweytick D, Athenstaedt K, Daum G. Intracellular lipid particles of eukary-
otic cells. Biochim Biophys Acta. 2000;1469:101–20.
 16. Koch B, Schmidt C, Daum G. Storage lipids of yeasts: a survey of nonpolar 
lipid metabolism in Saccharomyces cerevisiae, Pichia pastoris, and Yarrowia 
lipolytica. FEMS Microbiol Rev. 2014;38:892–915.
 17. Grillitsch K, Connerth M, Köfeler H, Arrey TN, Rietschel B, Wagner B, 
Karas M, Daum G. Lipid particles/droplets of the yeast Saccharomyces 
cerevisiae revisited: lipidome meets proteome. Biochim Biophys Acta. 
2011;1811:1165–76.
 18. Fei W, Shui G, Zhang Y, Krahmer N, Ferguson C, Kapterian TS, Lin RC, 
Dawes IW, Brown AJ, Li P, Huang X, Parton RG, Wenk MR, Walther TC, 
Yang H. A role for phosphatidic acid in the formation of “supersized” lipid 
droplets. PLoS Genet. 2011;7:e1002201.
 19. Tai M, Stephanopoulos G. Engineering the push and pull of lipid bio-
synthesis in oleaginous yeast Yarrowia lipolytica for biofuel production. 
Metab Eng. 2013;15:1–9.
 20. Beopoulos A, Mrozova Z, Thevenieau F, Le Dall M-T, Hapala I, Papan-
ikolaou S, Chardot T, Nicaud J-M. Control of lipid accumulation in the 
yeast Yarrowia lipolytica. Appl Environ Microbiol. 2008;74:7779–89.
 21. Blazeck J, Hill A, Liu L, Knight R, Miller J, Pan A, Otoupal P, Alper HS. Har-
nessing Yarrowia lipolytica lipogenesis to create a platform for lipid and 
biofuel production. Nat Commun. 2014;5:3131.
Page 12 of 12Friedlander et al. Biotechnol Biofuels  (2016) 9:77 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 22. Qiao K, Imam Abidi SH, Liu H, Zhang H, Chakraborty S, Watson N, 
Kumaran Ajikumar P, Stephanopoulos P. Engineering lipid overproduction 
in the oleaginous yeast Yarrowia lipolytica. Metab Eng. 2015;29:56–65.
 23. Liu L, Pan A, Spofford C, Zhou N, Alper HS. An evolutionary metabolic 
engineering approach for enhancing lipogenesis in Yarrowia lipolytica. 
Metab Eng. 2015;29:36–45.
 24. Liu L, Markham K, Blazeck J, Zhou N, Leon D, Otoupal P, Alper HS. Survey-
ing the lipogenesis landscape in Yarrowia lipolytica through understand-
ing the function of a Mga2p regulatory protein mutant. Metab Eng. 
2015;31:102–11.
 25. Beopoulos A, Haddouche R, Kabran P, Dulermo T, Chardot T, Nicaud J-M. 
Identification and characterization of DGA2, an acyltransferase of the 
DGAT1 acyl-CoA:diacylglycerol acyltransferase family in the oleaginous 
yeast Yarrowia lipolytica. New insights into the storage lipid metabolism 
of oleaginous yeasts. Appl Microbiol Biotechnol. 2012;93:1523–37.
 26. Gajdoš P, Nicaud J-M, Rossignol T, Čertík M. Single cell oil production on 
molasses by Yarrowia lipolytica strains overexpressing DGA2 in multicopy. 
Appl Microbiol Biotechnol. 2015:1–10.
 27. Athenstaedt K, Jolivet P, Boulard C, Zivy M, Negroni L, Nicaud J-M, Char-
dot T. Lipid particle composition of the yeast Yarrowia lipolytica depends 
on the carbon source. Proteomics. 2006;6:1450–9.
 28. Courchesne NMD, Parisien A, Wang B, Lan CQ. Enhancement of lipid pro-
duction using biochemical, genetic and transcription factor engineering 
approaches. J Biotechnol. 2009;141:31–41.
 29. Zhang S, Skerker JM, Rutter CD, Maurer MJ, Arkin AP, Rao CV. Engineer-
ing Rhodosporidium toruloides for increased lipid production. Biotechnol 
Bioeng. 2015. doi:10.1002/bit.25864.
 30. Meyer K, Stecca KL. Plant seeds with altered storage compound levels, 
related constructs and methods involving genes encoding oxidoreduc-
tase motif polypeptides. 2013. WO2011109618 A2.
 31. Dulermo T, Tréton B, Beopoulos A, Kabran Gnankon AP, Haddouche 
R, Nicaud J-M. Characterization of the two intracellular lipases of Y. 
lipolytica encoded by TGL3 and TGL4 genes: new insights into the role of 
intracellular lipases and lipid body organisation. Biochim Biophys Acta. 
2013;1831:1486–95.
 32. Athenstaedt K. YALI0E32769 g (DGA1) and YALI0E16797 g (LRO1) encode 
major triacylglycerol synthases of the oleaginous yeast Yarrowia lipolytica. 
Biochim Biophys Acta. 2011;1811:587–96.
 33. Oelkers P, Cromley D, Padamsee M, Billheimer JT, Sturley SL. The DGA1 
gene determines a second triglyceride synthetic pathway in yeast. J Biol 
Chem. 2002;277:8877–81.
 34. Valanne S, Wang J-H, Rämet M. The Drosophila Toll signaling pathway. J 
Immunol. 2011;186:649–56.
 35. Reed DE, Huang XM, Wohlschlegel JA, Levine MS, Senger K. DEAF-1 regu-
lates immunity gene expression in Drosophila. Proc Natl Acad Sci USA. 
2008;105:8351–6.
 36. Stark A, Lin MF, Kheradpour P, Pedersen JS, Parts L, Carlson JW, Crosby 
MA, Rasmussen MD, Roy S, Deoras AN, Ruby JG, Brennecke J, Curators 
HF, Project BDG, Hodges E, Hinrichs AS, Caspi A, Paten B, Park S-W, Han 
MV, Maeder ML, Polansky BJ, Robson BE, Aerts S, van Helden J, Hassan B, 
Gilbert DG, Eastman DA, Rice M, Weir M, et al. Discovery of functional ele-
ments in 12 Drosophila genomes using evolutionary signatures. Nature. 
2007;450:219–32.
 37. Sitepu IR, Sestric R, Ignatia L, Levin D, German JB, Gillies LA, Almada LAG, 
Boundy-Mills KL. Manipulation of culture conditions alters lipid content 
and fatty acid profiles of a wide variety of known and new oleaginous 
yeast species. Bioresour Technol. 2013;144:360–9.
 38. Liang M-H, Jiang J-G. Advancing oleaginous microorganisms to 
produce lipid via metabolic engineering technology. Prog Lipid Res. 
2013;52:395–408.
 39. Ageitos JM, Vallejo JA, Veiga-Crespo P, Villa TG. Oily yeasts as oleaginous 
cell factories. Appl Microbiol Biotechnol. 2011;90:1219–27.
 40. Kaneko H, Hosohara M, Tanaka M, Itoh T. Lipid composition of 30 species 
of yeast. Lipids. 1976;11:837–44.
 41. Zhu Z, Zhang S, Liu H, Shen H, Lin X, Yang F, Zhou YJ, Jin G, Ye M, Zou H, 
Zou H, Zhao ZK. A multi-omic map of the lipid-producing yeast Rho-
dosporidium toruloides. Nat Commun. 2012;3:1112.
 42. Tsakraklides V, Brevnova E, Stephanopoulos G, Shaw AJ. Improved 
gene targeting through cell cycle synchronization. PLoS One. 2015. 
doi:10.1371/journal.pone.01334.
 43. Wilfling F, Wang H, Haas JT, Krahmer N, Gould TJ, Uchida A, Cheng J-X, 
Graham M, Christiano R, Fröhlich F, Liu X, Buhman KK, Coleman RA, 
Bewersdorf J, Farese RV, Walther TC. Triacylglycerol synthesis enzymes 
mediate lipid droplet growth by relocalizing from the ER to lipid droplets. 
Dev Cell. 2013;24:384–99.
 44. Ratledge C. The role of malic enzyme as the provider of NADPH in oleagi-
nous microorganisms: a reappraisal and unsolved problems. Biotechnol 
Lett. 2014;36:1557–68.
 45. Lazar Z, Rossignol T, Verbeke J, Crutz-Le Coq A-M, Nicaud J-M, Robak M. 
Optimized invertase expression and secretion cassette for improving 
Yarrowia lipolytica growth on sucrose for industrial applications. J Ind 
Microbiol Biotechnol. 2013;40:1273–83.
 46. Stephanopoulos G, Tai M. Engineered microbes and methods for micro-
bial oil overproduction from cellulosic materials. US Patent 20130344548 
A1 2013.
 47. Wei H, Wang W, Alahuhta M, Vander Wall T, Baker JO, Taylor LE, Decker SR, 
Himmel ME, Zhang M. Engineering towards a complete heterologous 
cellulase secretome in Yarrowia lipolytica reveals its potential for consoli-
dated bioprocessing. Biotechnol Biofuels. 2014;7:148.
 48. Ledesma-Amaro R, Dulermo T, Nicaud JM. Engineering Yarrowia lipolytica 
to produce biodiesel from raw starch. Biotechnol Biofuels. 2015;8:148.
 49. Papanikolaou S, Aggelis G. Lipid production by Yarrowia lipolytica grow-
ing on industrial glycerol in a single-stage continuous culture. Bioresour 
Technol. 2002;82:43–9.
 50. Rakicka M, Lazar Z, Dulermo T, Fickers P, Nicaud JM. Lipid production 
by the oleaginous yeast Yarrowia lipolytica using industrial by-products 
under different culture conditions. Biotechnol Biofuels. 2015;8:104.
 51. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. Cold 
Spring Harbor: Cold Spring Harbor Lab Press; 2001.
 52. Shanks RMQ, Caiazza NC, Hinsa SM, Toutain CM, O’Toole GA. Saccharo-
myces cerevisiae-based molecular tool kit for manipulation of genes from 
gram-negative bacteria. Appl Environ Microbiol. 2006;72:5027–36.
 53. Chen DC, Beckerich JM, Gaillardin C. One-step transformation of 
the dimorphic yeast Yarrowia lipolytica. Appl Microbiol Biotechnol. 
1997;48:232–5.
